ABL Bio financial statements

에이비엘바이오KRX:298380 · KOSDAQ · Healthcare · sector #23
₩52,500+2.14%
2026-10-06 close

ABL Bio's published financial data is dated 2026-10-04. 2024 revenue was KRW 33.4B. 2024 operating profit was −KRW 59.38B.

Reported results

ABL Bio notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q